WHO Vector Control Response highlights critical importance of innovation

Proposed at the recent 70th World Health Assembly, the aim of the Global Vector Control Response (GVCR) is to reduce the burden and threat of vector borne diseases such as Zika, dengue and chikungunya.

Acknowledging the urgent need to re-align vector control programs and to increase global capacity, the GVCR also highlights the importance of investing in innovative new technologies, such as Eliminate Dengue Program’s self-sustaining Wolbachia method.

By supporting the implementation of a comprehensive approach to vector control, the GVCR will also help to achieve disease-specific national and global goals and contribute to the UN Sustainable Development Goals. In particular, the Response contributes to targets for Goal #3: ensuring good health and well-being, which is supported by the Eliminate Dengue Program.

In March 2016, a Vector Control Advisory Group (VCAG) convened by the World Health Organization issued a statement recommending further pilot deployments of the EDP’s Wolbachia method. Following almost six years of small-scale field trials in five countries, EDP received a major increase in government and philanthropic support to commence large-scale trials in October 2016. 

View the dedicated resolution adopted by WHO Members States.